Cargando…

Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis

OBJECTIVES: The prevalence of end-stage renal disease (ESRD) and the number of patients undergoing dialysis in Taiwan are high. Since September 2009, the National Health Insurance has started to provide hospice care to patients with renal failure in Taiwan. Therefore, it is necessary to understand t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu-Chen, Hu, Kai-Chieh, Chang, Wei-Chuan, Hsu, Chung-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020240/
https://www.ncbi.nlm.nih.gov/pubmed/35465279
http://dx.doi.org/10.4103/tcmj.tcmj_207_21
_version_ 1784689494716317696
author Wang, Shu-Chen
Hu, Kai-Chieh
Chang, Wei-Chuan
Hsu, Chung-Y.
author_facet Wang, Shu-Chen
Hu, Kai-Chieh
Chang, Wei-Chuan
Hsu, Chung-Y.
author_sort Wang, Shu-Chen
collection PubMed
description OBJECTIVES: The prevalence of end-stage renal disease (ESRD) and the number of patients undergoing dialysis in Taiwan are high. Since September 2009, the National Health Insurance has started to provide hospice care to patients with renal failure in Taiwan. Therefore, it is necessary to understand the use of hospice and nonhospice care in patients with ESRD on dialysis. We aim to understand trends in patients with ESRD receiving hospice and nonhospice care as well as medical care efforts during the last month of their lives (2009–2013). MATERIALS AND METHODS: The cohort study was conducted using 1 million randomly selected samples from the Taiwan Health Insurance Research Database for millions of people in Taiwan in 2009–2013. Descriptive statistics were presented to summarize the characteristics of data. To compare differences between cohorts, Chi-square tests and Student's t-tests were used. Mann–Whitney U-tests were performed for nonnormally distributed data. Mantel–Haenszel test was test for trend. RESULTS: We recruited 770 ESRD patients who underwent hemodialysis; among them, 154 patients received hospice care. Patients who received hospice care had a significantly longer survival time after removal of mechanical ventilator (20 vs. 0 days) and after discontinuation of dialysis (2 vs. 0 days) compared with those who did not receive hospice care. Patients who received hospice care had more pain control (61.04% vs. 17.37%, P < 0.0001) and other symptomatic control (55.84% vs. 43.18% with diuretics, P < 0.05; 64.29% and 48.21% with laxatives, P = 0.0004) medications than those who did not. Nevertheless, the overall medical cost in the hospice group was significantly lower (90 USD and 280 USD, P < 0.0001). CONCLUSION: Our results suggest that the addition of hospice care may permit patients a longer life-support-free survival time. In addition, despite a more frequent symptomatic controlling agent use, hospice care significantly reduced the overall medical expenditure.
format Online
Article
Text
id pubmed-9020240
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90202402022-04-21 Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis Wang, Shu-Chen Hu, Kai-Chieh Chang, Wei-Chuan Hsu, Chung-Y. Tzu Chi Med J Original Article OBJECTIVES: The prevalence of end-stage renal disease (ESRD) and the number of patients undergoing dialysis in Taiwan are high. Since September 2009, the National Health Insurance has started to provide hospice care to patients with renal failure in Taiwan. Therefore, it is necessary to understand the use of hospice and nonhospice care in patients with ESRD on dialysis. We aim to understand trends in patients with ESRD receiving hospice and nonhospice care as well as medical care efforts during the last month of their lives (2009–2013). MATERIALS AND METHODS: The cohort study was conducted using 1 million randomly selected samples from the Taiwan Health Insurance Research Database for millions of people in Taiwan in 2009–2013. Descriptive statistics were presented to summarize the characteristics of data. To compare differences between cohorts, Chi-square tests and Student's t-tests were used. Mann–Whitney U-tests were performed for nonnormally distributed data. Mantel–Haenszel test was test for trend. RESULTS: We recruited 770 ESRD patients who underwent hemodialysis; among them, 154 patients received hospice care. Patients who received hospice care had a significantly longer survival time after removal of mechanical ventilator (20 vs. 0 days) and after discontinuation of dialysis (2 vs. 0 days) compared with those who did not receive hospice care. Patients who received hospice care had more pain control (61.04% vs. 17.37%, P < 0.0001) and other symptomatic control (55.84% vs. 43.18% with diuretics, P < 0.05; 64.29% and 48.21% with laxatives, P = 0.0004) medications than those who did not. Nevertheless, the overall medical cost in the hospice group was significantly lower (90 USD and 280 USD, P < 0.0001). CONCLUSION: Our results suggest that the addition of hospice care may permit patients a longer life-support-free survival time. In addition, despite a more frequent symptomatic controlling agent use, hospice care significantly reduced the overall medical expenditure. Wolters Kluwer - Medknow 2021-12-09 /pmc/articles/PMC9020240/ /pubmed/35465279 http://dx.doi.org/10.4103/tcmj.tcmj_207_21 Text en Copyright: © 2021 Tzu Chi Medical Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Wang, Shu-Chen
Hu, Kai-Chieh
Chang, Wei-Chuan
Hsu, Chung-Y.
Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title_full Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title_fullStr Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title_full_unstemmed Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title_short Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
title_sort utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020240/
https://www.ncbi.nlm.nih.gov/pubmed/35465279
http://dx.doi.org/10.4103/tcmj.tcmj_207_21
work_keys_str_mv AT wangshuchen utilizationofhospiceandnonhospicecareinpatientswithendstagerenaldiseaseondialysis
AT hukaichieh utilizationofhospiceandnonhospicecareinpatientswithendstagerenaldiseaseondialysis
AT changweichuan utilizationofhospiceandnonhospicecareinpatientswithendstagerenaldiseaseondialysis
AT hsuchungy utilizationofhospiceandnonhospicecareinpatientswithendstagerenaldiseaseondialysis